News | September 08, 2014

MedStar Georgetown to Install Mevion S250 Proton Therapy System to Treat Adult and Pediatric Cancer Patients

MedStar Georgetown University Hospital to bring first proton therapy center to Washington, D.C.

MedStar Georgetown to Install Mevion S250 Proton Therapy System to Treat Adult and Pediatric Cancer Patients

September 8, 2014 — Mevion Medical Systems announced that MedStar Georgetown University Hospital has received final approval to begin construction of the first proton therapy center in Washington, D.C., at its Lombardi Comprehensive Cancer Center.

Georgetown Lombardi is the only cancer center in the D.C. area to earn the National Cancer Institute (NCI) designation as a comprehensive cancer center. The Mevion S250, the world’s smallest single-room proton therapy system, delivers the same precise, noninvasive treatment advantages and capabilities of larger, more expensive proton therapy systems but with a significantly reduced footprint, improved reliability, more efficient patient access, and dramatically lower implementation and operational costs.

Proton therapy is an advanced form of external radiation treatment that aims a powerful beam of protons at a tumor with incredible accuracy. Because of the special properties of protons, treatments result in less damage to surrounding healthy tissue and a reduced risk of secondary malignancies. Proton therapy is commonly used to treat a wide range of cancers in sensitive locations, such as the central nervous system, chest, head and neck, eye, and prostate. This advanced form of radiation is extremely valuable for the treatment of cancer in pediatric patients, who can be more prone to complications from radiation treatment.

Construction is scheduled to start in the fall, with installation of the Mevion S250 to be complete in 2016.

“The addition of proton therapy to our experienced and internationally known cancer program is a natural progression for us as the only provider in the region with a long history of serving both children as well as adults with cancer,” said Richard Goldberg, M.D., president, MedStar Georgetown University Hospital. “We are excited to bring this important technology to our community and to give our patients yet another cutting-edge cancer treatment option.”

“The Mevion S250 proton therapy system provides a significant benefit to cancer patients while redefining the economics and accessibility of proton therapy,” said Joseph K. Jachinowski, president and CEO of Mevion Medical Systems. “We are proud to bring the most advanced radiation therapy device to our nation’s capital and another leading healthcare institution.”

For more information: www.mevion.com, www.lombardi.georgetown.edu

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...